Substitution of Generic Drugs and Biosimilars
| Errataetall: |
CommentOn: JAMA Intern Med. 2021 Jan 1;181(1):16-22. - PMID 32865564 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:181 |
|---|---|
| Enthalten in: |
JAMA internal medicine - 181(2021), 4 vom: 01. Apr., Seite 567-568 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cho, Sang Kyu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biosimilar Pharmaceuticals |
|---|
| Anmerkungen: |
Date Completed 03.01.2022 Date Revised 03.01.2022 published: Print CommentOn: JAMA Intern Med. 2021 Jan 1;181(1):16-22. - PMID 32865564 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamainternmed.2020.8561 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320544621 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320544621 | ||
| 003 | DE-627 | ||
| 005 | 20231225173817.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamainternmed.2020.8561 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320544621 | ||
| 035 | |a (NLM)33492392 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cho, Sang Kyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Substitution of Generic Drugs and Biosimilars |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2022 | ||
| 500 | |a Date Revised 03.01.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA Intern Med. 2021 Jan 1;181(1):16-22. - PMID 32865564 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Biosimilar Pharmaceuticals |2 NLM | |
| 650 | 7 | |a Drugs, Generic |2 NLM | |
| 700 | 1 | |a Jun, Hankyung |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA internal medicine |d 2013 |g 181(2021), 4 vom: 01. Apr., Seite 567-568 |w (DE-627)NLM220635021 |x 2168-6114 |7 nnns |
| 773 | 1 | 8 | |g volume:181 |g year:2021 |g number:4 |g day:01 |g month:04 |g pages:567-568 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamainternmed.2020.8561 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 181 |j 2021 |e 4 |b 01 |c 04 |h 567-568 | ||